Results generated from a syngeneic breast cancer model have corroborated that inhibition of SK1 in tumor cells decreased S1P levels and lung and lymph nodes metastasis through the disruption of angiogenesis and lymphangiogenesis [24]. Here, SPHK1 is linked to breast cancer.